Evidence map›Paper›PMID 37569428›Full record

ArticleInternational journal of molecular sciences2023

The Combined Metabolically Oriented Effect of Fucoidan from the Brown Alga

Olesya S Malyarenko, Roza V Usoltseva, Artem S Silchenko, Anastasiya O Zueva, Svetlana P Ermakova

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Olesya S MalyarenkoG.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Pr. 100-Letiya Vladivostoka 159, 690022 Vladivostok, Russia.ORCID 0000-0002-3262-0373
Roza V UsoltsevaG.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Pr. 100-Letiya Vladivostoka 159, 690022 Vladivostok, Russia.ORCID 0009-0002-1519-1519
Artem S SilchenkoG.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Pr. 100-Letiya Vladivostoka 159, 690022 Vladivostok, Russia.ORCID 0000-0002-3502-5692
Anastasiya O ZuevaG.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Pr. 100-Letiya Vladivostoka 159, 690022 Vladivostok, Russia.ORCID 0000-0001-9570-7647
Svetlana P ErmakovaG.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Pr. 100-Letiya Vladivostoka 159, 690022 Vladivostok, Russia.
Pacific Institute of Bioorganic Chemistry. GB Elyakova Far Eastern Branch of the Russian Academy of Sciences · RU

Funding

Russian Science Foundation 21-14-00321
6 · The paper itself

Abstract

Melanoma is the most aggressive and treatment-resistant form of skin cancer. It is phenotypically characterized by aerobic glycolysis that provides higher proliferative rates and resistance to cell death. The glycolysis regulation in melanoma cells by means of effective metabolic modifiers represents a promising therapeutic opportunity. This work aimed to assess the metabolically oriented effect and mechanism of action of fucoidan from the brown alga

Indexed as

LaminariaMelanomaCell Line, TumorCell ProliferationDeoxyglucoseGlucoseHumansPolysaccharidesDeoxyglucosefucoidanGlucosePolysaccharides2-deoxy-D-glucosecarboxymethylated fucoidanfucoidanglycolysismelanomaSaccharina cichorioidesSK-MEL-28 cells

Identifiers

PMID37569428
PMCPMC10418387
OpenAlexW4385346851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.